Changes in Insulin: Glucose, Glucagon: Glucose, and Insulin: Glucagon Ratios Correlate with Glycemic Response in Patients with Type 2 Diabetes Treated with Saxagliptin Plus Dapagliflozin Add-on to Metformin Therapy

被引：0
|
作者：
Hansen, Lars
Iqbal, Nayyar
Elkholm, Ella
Chen, Hungta
Cook, William
Hirshberg, Boaz
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1212-P
引用
收藏
页码：A313 / A313
页数：1
相关论文
共 50 条
  • [1] POSTPRANDIAL DYNAMICS OF PLASMA GLUCOSE, INSULIN, AND GLUCAGON IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH SAXAGLIPTIN PLUS DAPAGLIFLOZIN ADD-ON TO METFORMIN THERAPY
    Hansen, Lars
    Iqbal, Nayyar
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    ENDOCRINE PRACTICE, 2014, 20 (11) : 1187 - 1197
  • [2] INSULIN AND GLUCAGON RESPONSE TO ARGININE AND GLUCOSE IN METFORMIN TREATED RATS
    COSCELLI, C
    BOBBIONI, E
    BUTTURINI, U
    DIABETOLOGIA, 1978, 15 (03) : 225 - 225
  • [3] Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial
    Vilsboll, Tina
    Ekholm, Ella
    Johnsson, Eva
    Dronamraju, Nalina
    Jabbour, Serge
    Lind, Marcus
    DIABETES CARE, 2019, 42 (08) : 1464 - 1472
  • [4] Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
    Mueller-Wieland, Dirk
    Kellerer, Monika
    Cypryk, Katarzyna
    Skripova, Dasa
    Rohwedder, Katja
    Johnsson, Eva
    Garcia-Sanchez, Ricardo
    Kurlyandskaya, Raisa
    Sjostrom, C. David
    Jacob, Stephan
    Seufert, Jochen
    Dronamraju, Nalina
    Csomos, Katalin
    DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2598 - 2607
  • [5] Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin
    Barnett, Anthony H.
    Charbonnel, Bernard
    Donovan, Mark
    Fleming, Douglas
    Chen, Roland
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (04) : 513 - 523
  • [6] Dapagliflozin plus Saxagliptin Add-On vs. Glimepiride Add-On to Metformin in Patients with Poorly Controlled Type 2 Diabetes
    Frias, Juan P.
    Gonzalez-Galvez, Guillermo
    Johnsson, Eva K.
    Maaske, Jill
    Peters, Anne
    DIABETES, 2018, 67
  • [7] Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin
    Rosenstock, Julio
    Mathieu, Chantal
    Chen, Hungta
    Garcia-Sanchez, Ricardo
    Saraiva, Gabriela Luporini
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (04): : 424 - 430
  • [8] Dapagliflozin plus saxagliptin plus metformin triple therapy vs sitagliptin add-on to metformin dual therapy in subgroups of patients with uncontrolled type 2 diabetes
    Del Prato, S.
    Handelsman, Y.
    Mathieu, C.
    Johnsson, E.
    Kurlyandskaya, R.
    Iqbal, N.
    Garcia-Sanchez, R.
    Rosenstock, J.
    DIABETOLOGIA, 2017, 60 : S20 - S21
  • [9] EFFECTS OF METFORMIN OR ACARBOSE AS ADD-ON TO INSULIN THERAPY ON GLYCEMIC VARIABILITY IN TYPE 2 DIABETES
    Lu, J.
    Xiaojing, M.
    Lei, Z.
    Yifei, M.
    Lingwen, Y.
    Wei, L.
    Wei, Z.
    Yuqian, B.
    Jian, Z.
    Weiping, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A61 - A62
  • [10] Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes
    Matthaei, Stephan
    Catrinoiu, Doina
    Celinski, Aleksander
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Chen, Hungta
    Iqbal, Nayyar
    Hansen, Lars
    DIABETES CARE, 2015, 38 (11) : 2018 - 2024
12345